<unk>  (BMY-13,859), also sometimes called<unk>  or<unk> , is an atypical antipsychotic of the azapirone class. It was investigated as a treatment for schizophrenia in the late 1980s and was found to have an effectiveness equivalent to those of typical antipsychotics in clinical trials but without causing extrapyramidal side effects. However, development was halted and it was not marketed. Perospirone, another azapirone derivative with antipsychotic properties, was synthesized and assayed several years after<unk> . It was found to be both more potent and more selective in comparison and was commercialized instead.
Tiospirone
Perospirone
Tandospirone
Tetherin
Survivin
Parkin 
Tetraspanin
Dystrophin